Fig. 2From: The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi ArabiaRelative risks for adverse events according to estimated treatment effects [18]. GI, gastrointestinalBack to article page